AR129413A2 - SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE - Google Patents
SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USEInfo
- Publication number
- AR129413A2 AR129413A2 ARP230101296A ARP230101296A AR129413A2 AR 129413 A2 AR129413 A2 AR 129413A2 AR P230101296 A ARP230101296 A AR P230101296A AR P230101296 A ARP230101296 A AR P230101296A AR 129413 A2 AR129413 A2 AR 129413A2
- Authority
- AR
- Argentina
- Prior art keywords
- drug conjugates
- methods
- antibody
- drug
- splicing modulator
- Prior art date
Links
- 239000000611 antibody drug conjugate Substances 0.000 title abstract 4
- 229940049595 antibody-drug conjugate Drugs 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se divulgan compuestos de enlazador-fármaco y conjugados anticuerpo-fármaco que se unen a blancos de oncología humana. Los compuestos de enlazador-fármaco y los conjugados anticuerpo-fármaco comprenden un resto farmacológico de modulador de empalme. La divulgación además se refiere a métodos y composiciones para usar en el tratamiento de trastornos neoplásicos administrando los conjugados anticuerpo-fármaco proporcionados en la presente.Disclosed are linker-drug compounds and antibody-drug conjugates that bind to human oncology targets. The linker-drug compounds and antibody-drug conjugates comprise a splicing modulator drug moiety. The disclosure further relates to methods and compositions for use in treating neoplastic disorders by administering the antibody-drug conjugates provided herein.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862679631P | 2018-06-01 | 2018-06-01 | |
| US202062679672P | 2020-06-01 | 2020-06-01 | |
| US202062779324P | 2020-12-13 | 2020-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR129413A2 true AR129413A2 (en) | 2024-08-21 |
Family
ID=92542021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230101296A AR129413A2 (en) | 2018-06-01 | 2023-05-23 | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR129413A2 (en) |
-
2023
- 2023-05-23 AR ARP230101296A patent/AR129413A2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2024001239A1 (en) | Splicing-modulating antibody-drug conjugates and methods of use. | |
| CL2021001534A1 (en) | Herboxydiene of antibody-drug conjugates and methods of use. | |
| CL2021000049A1 (en) | Eribulin-Based Drug-Antibody Conjugates and Methods for Their Use (Divisional Application 2456-2018) | |
| MX2019008208A (en) | METHODS TO TREAT CANCER WITH ANTI-TIM-3 ANTIBODIES. | |
| UY39188A (en) | IMIDAZOPYRIDAZINES AS IL-17 MODULATORS | |
| CR20160271A (en) | PEPTIDOMETIC COMPOUNDS AND THEIR ANTIBODY-DRUG CONJUGATES | |
| CO2022007924A2 (en) | Anti-mesothelin eribulin antibody drug conjugates and methods of use | |
| CO2022003703A2 (en) | therapeutic conjugates | |
| CO2020016151A2 (en) | Anti-sez6 Antibody-Drug Conjugates and Methods of Use | |
| MX2020010110A (en) | DRUG CONJUGATES OF CMET MONOCLONAL BINDING AGENTS, AND USES THEREOF. | |
| AR129413A2 (en) | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | |
| AR117589A1 (en) | SPLIT-DRUG MODULATOR ANTIBODY CONJUGATES AND METHODS OF USE | |
| AR117686A1 (en) | HERBOXIDIENE SPLIT MODULATOR OF ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | |
| CO2023008051A2 (en) | Anti-cd48 antibodies, antibody-drug conjugates, and uses thereof | |
| AR129382A1 (en) | BCL-XL AND MET INHIBITORS ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE | |
| EA202092951A1 (en) | ANTIBODY AND DRUG CONJUGATES AS A SPLICING MODULATOR AND METHODS OF THEIR APPLICATION | |
| AR098781A1 (en) | PEPTIDOMIMETIC COMPOUNDS AND ANTIBODY-DRUG CONJUGATES OF THE SAME |